Our collaborative approach creates distinctive vaccine solutions.
Differentiate your vaccines by effectiveness, cost and value.
Develop next-generation biologics or enhance traditional vaccines.
Maximize the safety, effectiveness and marketability of vaccines.
VaxLiant is a new joint venture designed to modernize how vaccines deliver antigens to prevent disease.
We provide innovative antigen-delivery systems and support that give the flexibility you need to develop and commercialize safe, effective vaccines.
Our portfolio of ready-to-use ENABL™ adjuvants and fully customizable Biomize™ antigen-delivery systems are backed by a team of technical and marketing experts. Together, they offer you unparalleled adaptability to streamline development of vaccines that protect against disease.